跳至主要内容
临床试验/NCT04025710
NCT04025710已完成不适用

BIO|MASTER.BIOMONITOR III

Biotronik SE & Co. KG27 个研究点 分布在 6 个国家目标入组 167 人开始时间: 2019年10月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
167
试验地点
27
主要终点
SADE-free Rate Until the 3-month Follow-up

研究概览

简要总结

This study is a post-market clinical follow-up (PMCF) study to identify and evaluate residual risks associated with the use of the BIOMONITOR III and BIOMONITOR IIIm that are discovered or remain even after risk analysis, risk mitigation and successful conformity assessment. Furthermore, this study will also provide additional data as required by regulatory authorities outside of the CE-region.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is at high risk of developing a clinically important cardiac arrhythmia; or
  • Patient is undergoing investigation for symptoms such as palpitations, pre- syncope or syncope, that are suggestive of an underlying cardiac arrhythmia; or
  • Patient is undergoing investigation for the detection of atrial fibrillation following cryptogenic stroke; or
  • Patient is planned for AF ablative procedure or has already undergone an AF ablative procedure.
  • Patient is able to understand the nature of the study and able to provide written informed consent.
  • Patient is willing and able to perform all follow-up visits at the investigational site.
  • Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept.

排除标准

  • Patient is implanted with an ICD or pacemaker.
  • Patient is pregnant or breast-feeding.
  • Patient is less than 18 years old.
  • Patient's life-expectancy is less than 12 months.
  • Patient is participating in another interventional clinical investigation.

结局指标

主要结局

SADE-free Rate Until the 3-month Follow-up

时间窗: 3 months

SADE-free rate related to BIOMONITOR III and BIOMONITOR IIIm including incision and insertion tool set until 3-month follow-up

次要结局

  • Noise Burden(10 days to 4 weeks after insertion; 3-months)
  • R-wave Amplitude(10 days to 4 weeks after insertion; 3-months)
  • SADE-free Rate Until the 12-month Follow-up(12-months)
  • Assessment of P-wave Visibility(10 days to 4 weeks after insertion; 3-months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (27)

Loading locations...

相似试验